Supporting Statement for Paperwork Reduction Act Submissions: Standards Related to Reinsurance, Risk Corridors, Risk Adjustment, and Payment Appeals (CMS-10401/OMB Control Number 0938-1155
The Patient Protection and Affordable Care Act, Public Law 111-148, enacted on March 23, 2010, and the Health Care and Education Reconciliation Act, Public Law 111-152, enacted on March 30, 2010 [collectively, the “Patient Protection and Affordable Care Act” (ACA)], provided for three premium stabilization programs – a transitional reinsurance program, a temporary risk corridors program, and a permanent risk adjustment program (the 3Rs programs) – to mitigate the negative impacts of adverse selection and market uncertainty. This document focuses on the data collection requirements related to the 3Rs programs.
Established by Section 1341 of the ACA, the transitional reinsurance program was applicable for the 2014–2016 benefit years. Currently, close-out activities continue for this program, and are expected to continue into 2022 or beyond, as required.
Established by Section 1342 of the ACA, the temporary risk corridors program was applicable for the 2014–2016 benefit years. No close-out activities remain for the risk corridors program.
Established by Section 1343 of the ACA, the permanent risk adjustment program transfers funds from lower risk, non-grandfathered plans to higher risk, non-grandfathered plans in the individual and small group markets, inside and outside the Exchanges. Some notable changes to the risk adjustment program are as follows:
We updated External Data Gathering Environment (EDGE) data collection by including two new data elements: (1) regarding pharmacy claims, the number of days’ supply for prescription drugs, and (2) an in/out-of-network claims indicator.
Beginning for the 2018 benefit year, the HHS risk adjustment program included the high- cost risk pool where an issuer’s aggregated paid claims costs for an enrollee are partially reimbursed when those costs exceed a specific cost threshold.
In the 2019 Payment Notice, we allowed state regulators, beginning for the 2020 benefit year, to request a reduction to risk adjustment transfers in the individual, small group or merged markets.
For the 2018 benefit year, the Department of Health and Human Services (HHS) began
1
making payment adjustments under the audit of the risk adjustment program, referred to as risk adjustment data validation (HHS-RADV). In the HHS Notice of Benefit and Payment Parameters for 2019 final rule (“2019 Payment Notice,” 83 FR 16930), starting with the 2017 benefit year HHS-RADV, for purposes of validating a diagnosis in HHS-RADV, we permitted issuers to provide mental and behavioral health assessments rather than full medical records, as was previously required.
The regulatory history of the 3Rs programs is as follows:
Standards Related to Reinsurance, Risk Corridors and Risk Adjustment (“Premium Stabilization Rule,” 77 FR 17220): On March 23, 2012, HHS published the Premium Stabilization Rule to implement and set standards for the reinsurance, risk corridors, and risk adjustment programs.
HHS Notice of Benefit and Payment Parameters for 2014 final rule (“2014 Payment Notice,” 78 FR 15410): On March 11, 2013, HHS published the 2014 Payment Notice to implement requirements for various programs established by the ACA, including the risk adjustment program in states where HHS operates risk adjustment, and to expand on standards related to the 3Rs programs set forth in the Premium Stabilization Rule. This rule also finalized six steps for error estimation for HHS-RADV and further clarified HHS- RADV policies.
Program Integrity: Exchange, Premium Stabilization Programs, and Market Standards (“Program Integrity Rule II,” 78 FR 65046): On October 30, 2013, HHS published the Program Integrity Rule II to outline financial integrity and oversight standards with respect to state-operated risk adjustment and reinsurance programs, including provisions governing reporting requirements and restricting the use of reinsurance funds for administrative expenses. HHS also amended the risk adjustment payment transfer formula in order to accommodate community rated states that utilized family tiering rating factors.
HHS Notice of Benefit and Payment Parameters for 2015 final rule (“2015 Payment Notice,” 79 FR 13743): On March 11, 2014, HHS published the 2015 Payment Notice to expand upon, modify, and clarify the provisions of the Premium Stabilization Rule and the 2014 Payment Notice, including to reduce issuers’ sample size for HHS-RADV, and the first and second Program Integrity Rules (78 FR 54070 and 78 FR 65046). HHS also finalized HHS–RADV requirements related to sampling; IVA standards, SVA processes, and medical record review as the basis of enrollee risk score validation; the error estimation process and original methodology; and HHS–RADV appeals, oversight, and data security standards.
HHS Notice of Benefit and Payment Parameters for 2016 final rule (“2016 Payment Notice,” 80 FR 10750): On February 17, 2015, HHS published the 2016 Payment Notice to extend the good faith safe harbor for non-compliance with the HHS-operated risk adjustment and reinsurance data requirements through the 2015 calendar year. HHS also explained that if, in the last year of the risk corridors program, there were excess cumulative risk corridors collections that exceeded the cumulative risk corridors payments owed, HHS would implement an adjustment to the profit floor and administrative cost ceiling to increase risk corridors payments for eligible issuers for benefit year 2016.
HHS Notice of Benefit and Payment Parameters for 2017 final rule (“2017 Payment
Notice,” 81 FR 12204): On March 8, 2016, HHS published the 2017 Payment Notice to update the risk adjustment factors to reflect multiple years of claims data to better address any data lag and more accurately account for conditions with high-cost treatments. In addition, beginning with the 2017 benefit year, HHS recalibrated the risk adjustment model to trend specialty and traditional drug expenditures at separate growth rates from medical expenditures and incorporated preventive services into the simulation of plan liability. To encourage continued compliance with risk adjustment data submissions, beginning with the 2015 benefit year, HHS raised the default risk adjustment charge from the 75th percentile to the 90th percentile of absolute transfers nationwide as a percent of state average premium.
HHS Notice of Benefit and Payment Parameters for 2018 final rule (“2018 Payment Notice,” 81 FR 94058): On December 22, 2016, HHS published the 2018 Payment Notice which provided that beginning for the 2018 benefit year, to allow for risk adjustment transfers to be calculated based on the portion of statewide average premiums that reflects enrollees’ risk and not fixed administrative costs, HHS finalized an adjustment to reduce the calculation of statewide average premium used in the risk adjustment transfer formula by 14 percent to account for fixed administrative costs. HHS also updated the risk adjustment methodology to incorporate enrollment duration factors and prescription drug categories; adjusted for extremely high-cost enrollees through the incorporation of the high-cost risk pool; provided the authority for use of masked enrollee-level EDGE server data collected for actual risk adjustment calculations for calibration of HHS programs, including the Actuarial Value (AV) calculator and to better understand these markets; and updated EDGE server data collection by including two new data elements: (1) regarding pharmacy claims, the number of days’ supply for prescription drugs, and (2) an in/out-of- network claims indicator. HHS also provided that issuers of plans with 500 or fewer billable member months statewide would be exempt from hiring an initial validation auditor for HHS-RADV. HHS also established a discrepancy process and clarified certain aspects of the administrative appeals process for HHS-RADV.
HHS Notice of Benefit and Payment Parameters for 2019 final rule (“2019 Payment Notice,” 83 FR 16930): On April 17, 2018, HHS published the 2019 Payment Notice where HHS postponed the $15 million materiality threshold for HHS-RADV audits until 2018 benefit year HHS-RADV. HHS also permitted state regulators to request a reduction in the statewide average premium factor of the risk adjustment transfer formula, beginning with the 2020 benefit year. In addition, for 2017 benefit year HHS-RADV and beyond, HHS finalized an amended error estimation methodology to only adjust issuers’ risk scores when an issuer’s failure rate is materially different from other issuers based on three hierarchical condition category (HCC) groupings (low, medium, and high), that is, when an issuer is identified as an outlier. HHS also finalized a requirement that initial validation audit (IVA) samples only include enrollees from state market risk pools with more than one issuer; clarifications regarding civil money penalties for non-compliance with HHS– RADV; a process to handle demographic or enrollment errors discovered during HHS– RADV; and an exception to the prospective application of HHS–RADV results for exiting issuers, such that exiting outlier issuers’ results are used to adjust the benefit year being audited (rather than the following transfer year).
HHS Adoption of the Methodology for the HHS-Operated Permanent Risk Adjustment 3
Program Under the Patient protection and Affordable Care Act for the 2017 benefit year (“2018 RA Rule 1,” 83 FR 36456): On July 30, 2018, HHS published the 2018 RA Rule 1 that adopted the 2017 benefit year HHS-operated risk adjustment methodology set forth in the Premium Stabilization Rule and the 2017 Payment Notice. This rule set forth additional explanation of the rationale supporting the use of statewide average premium in the HHS-operated risk adjustment state payment transfer formula for the 2017 benefit year, including why the program is operated in a budget-neutral manner, and permitted HHS to resume 2017 benefit year program operations, including collection of risk adjustment charges and distribution of risk adjustment payments.
Adoption of the Methodology for the HHS-Operated Permanent Risk Adjustment Program for the 2018 Benefit Year Final Rule (“2018 RA Rule 2,” 83 FR 63419): On December
10, 2018, HHS published the 2018 RA Rule 2 to adopt the 2018 benefit year HHS- operated risk adjustment methodology as established in the Premium Stabilization Rule and 2018 Payment Notice, which permitted HHS to resume 2018 benefit year program operations, including collection of risk adjustment charges and distribution of risk adjustment payments.
HHS Notice of Benefit and Payment Parameters for 2020 final rule (“2020 Payment Notice,” 84 FR 17454): On April 25, 2019, HHS published the 2020 Payment Notice to, beginning with the 2018 benefit year, incorporate prescription drugs into HHS-RADV as a method of discovering materially incorrect EDGE data submissions, pilot the process of including prescription drugs into HHS-RADV for the 2018 benefit year, and finalize policies related to the application of issuer risk score error rates when an issuer exits all markets in a state or joins a previously single-issuer market. In addition, HHS established exemptions from HHS-RADV for issuers in liquidation who meet certain conditions, sole market risk pool issuers, and small group market issuers with off-calendar year coverage who exit the market but have only carry-over coverage that ends in the next benefit year. HHS also finalized a policy to create on an annual basis an Enrollee-Level EDGE Limited Data Set (LDS) using masked enrollee-level data submitted to EDGE servers by issuers of risk adjustment covered plans in the individual and small group (including merged) markets, and make this dataset available to requestors who seek the data for research purposes. Additionally, HHS finalized its proposal related to HHS-RADV to extend the Neyman allocation sampling methodology to the 10th stratum of enrollees without HCCs so that all 10 strata use this methodology.
HHS Notice of Benefit and Payment Parameters for 2021 final rule (“2021 Payment Notice,” 85 FR 29164): On May 14, 2020, HHS published the 2021 Payment Notice to finalize that, beginning with the 2021 benefit year, risk adjustment would blend the three most recent years of available enrollee-level EDGE data, and beginning with the 2019 benefit year HHS-RADV, HHS would not consider an issuer with fewer than 30 HCCs within an HCC failure rate group to be an outlier for that HCC failure rate group. Also, HHS established that it would continue to pilot the validation of prescription drug categories into HHS–RADV for the 2019 benefit year.
Amendments to the HHS-Operated Risk Adjustment Data Validation (HHS–RADV) Under the Patient Protection and Affordable Care Act’s HHS-Operated Risk Adjustment Program (“HHS-RADV Amendments Rule,” 85 FR 76979): On December 1, 2020, HHS published the HHS-RADV Amendments Rule to, beginning with the 2019 benefit year for
states where HHS operates the risk adjustment program, adopt a sliding scale adjustment to address a concern that issuers with failure rates that are just outside of the confidence intervals receive an adjustment to their risk scores, even though these issuers’ failure rates may not be significantly different from the failure rates of issuers just inside the confidence intervals who receive no risk score adjustment. HHS also finalized that HHS-RADV adjustments to risk scores and risk adjustment transfers would be applied beginning with the 2020 benefit year HHS-RADV.
HHS Notice of Benefit and Payment Parameters for 2022 final rule (“2022 Payment Notice,” 86 FR 24140): On May 5, 2021, HHS published the 2022 Payment Notice to finalize risk adjustment reporting requirements for issuers of risk adjustment covered plans who choose to provide temporary premium credits, if permitted by HHS during a future public health emergency, and to clarify the calculation of HHS risk adjustment payment and charges in light of these premium credits by specifying that, for states where issuers of risk adjustment covered plans provide temporary premium credits when permitted by HHS, the plan average premium and statewide average premium used in the state payment transfer formula would be calculated using issuers’ adjusted premium amounts. HHS also finalized the policy to use the three most recent consecutive years of enrollee-level EDGE data that are available in time for incorporating into the coefficients in the proposed rule and to not update the coefficients for additional years of data between the proposed and final rules if an additional year of enrollee-level EDGE data becomes available.
The transitional reinsurance program (for determining payments) and permanent risk adjustment program utilize the same data collection tool. For both programs, HHS collects issuers’ data needed for program calculations via a distributed data collection (DDC) approach referred to as the EDGE server.
The reporting and data collection provisions described below apply to states and health plans both inside and outside of an Exchange because “risk adjustment covered plan” is defined at 45 CFR §
153.20 as “for the purpose of the risk adjustment program, any health insurance coverage offered in the individual or small group market with the exception of grandfathered health plans, group health insurance coverage described in § 146.145(b) of this subchapter, individual health insurance coverage described in § 148.220 of this subchapter, and any plan determined not to be a risk adjustment covered plan in the applicable Federally certified risk adjustment methodology” and a “reinsurance-eligible plan” is defined at 45 CFR § 153.20 as “for the purpose of the reinsurance program, any health insurance coverage offered in the individual market, except for grandfathered plans and health insurance coverage not required to submit reinsurance contributions under § 153.400(a).”
HHS continues to recalibrate the risk adjustment models and refine the HHS-developed risk adjustment methodology to improve the risk adjustment program. This supporting statement proposes to reinstate with changes the existing collection to eliminate programs, revise existing estimates based on current operations, and update data collections to conform to statute and regulations. In all of our revised estimates, we have reduced the number of issuers affected to 650 from 2,400, based on experience from the initial years, and adjusted burden accordingly. We are also removing the data collection requirements related to the risk corridors program since data submissions associated with the final year and closeout activities for the risk corridors program
5
(2016 benefit year) have ended.
Section 1341 of the ACA provides that each state must establish a transitional reinsurance program to help stabilize premiums for coverage in the individual market during the first three years of Exchange operation. Section 1343 provides for a program of risk adjustment for all non-grandfathered plans in the individual and small group market both inside and outside of the Exchange. Sections 1402 and 1412 of the ACA establish a program for reducing cost sharing for individuals with lower household income and Indians. Sections 1401 and 1411 of the ACA provide for advance payments of the premium tax credit for low- and moderate- income enrollees in a qualified health plan (QHP) through an Exchange.
Section 1321(a) also provides broad authority for the Secretary to establish standards and regulations to implement the statutory requirements related to Exchanges, reinsurance, risk adjustment, and other components of title I of the ACA. These risk-spreading and insurance affordability programs, which will be implemented by HHS or states, are designed to mitigate adverse selection, to provide stability for health insurance issuers in the individual and small group markets as market reforms and Exchanges are implemented, and to make health insurance more affordable and accessible to millions of Americans who currently do not have affordable options available to them.
The data collection and reporting requirements described below will enable states, the District of Columbia, and HHS to implement these programs, which will mitigate the impact of adverse selection in the individual and small group markets both inside and outside the Exchange.
Information required by this collection will be submitted electronically. HHS staff will communicate with states and the District of Columbia using standardized reporting, e-mail, or telephone.
This information collection does not duplicate any other federal effort.
This information collection will not have a significant impact on small businesses.
The anticipated flows of funds for these programs require the collection of information as indicated. A less frequent collection could result in cash flow difficulties for issuers and logistical difficulties for issuers and the entities operating premium stabilization programs.
In order for charges to be collected and payments to be made in a timely manner for the risk adjustment program, it is necessary to collect information according to timeframes established by the state or HHS on behalf of the state. For program integrity and to confirm accurate payments were made, it is necessary to collect information according to timeframes established by the state or HHS on behalf of the state.
A 60-day Notice was published in the Federal Register on February 1, 2022 (87 FR 5483). One comment was received. While the comment is appreciated, it was outside of the scope of this data collection. The 30-day Federal Register Notice published on . No additional outside consultation was sought.
No payments or gifts will be provided to respondents.
We will maintain respondent privacy with respect to the information collected to the extent required by applicable law and HHS policies.
There are no sensitive questions included in this information collection effort.
Below is a summary of the information collection requirements set forth in the final rules and guidance cited above. Throughout this summary, the frequency of data collection is assumed to be the frequency discussed in these rules and guidance.
A number of assumptions are made regarding the wages of personnel needed to accomplish the proposed collection of information. Wage rates are based on the 2021 Employer Costs for Employee Compensation report by U.S. Bureau of Labor Statistics, available at https://www.bls.gov/oes/tables.htm, and represent a national average. Some states or employers may face higher or lower wage burdens. In this reinstatement with change, we have updated wage rates estimates to include a 100% fringe benefit estimate for all employees. We present an annualized estimate of the burden associated with these information collection requirements below.
Within Part 153, subpart E we discussed reporting requirements for health insurance issuers related to the transitional reinsurance program. As discussed above, this program ended in 2016 after most health insurance issuers and contributing entities provided HHS with data and made required reinsurance contributions and certain health insurance issuers provided HHS with data to receive reinsurance payments. However, we are still completing audits of issuers of reinsurance-eligible plans (i.e., those issuers who received
7
reinsurance payments) and making refunds to contributing entities as applicable. Additionally, we need to collect similar data to the data HHS collected in accordance with
§153.420(a) when HHS was making reinsurance payments from issuers operating in states that have requested HHS assistance to run a state-based reinsurance program (SRI) under an approved Section 1332 waiver. This data collection is described in conjunction with risk adjustment data submission requirements described in Part II below.
Audits and Compliance Reviews (§153.410(d))
HHS or its designee has the authority to audit and conduct compliance reviews of issuers of reinsurance-eligible plans to assess compliance with the requirements of subparts E and H of Part 153. For issuers of reinsurance-eligible plans, these provisions would result in a third-party disclosure requirement for issuers to prepare and compile the financial and programmatic information necessary to comply with the audit. Issuers being audited will also be required to comply with audit requirements including participating in entrance and exit conferences, submitting complete and accurate data to HHS in a timely manner, and providing responses to additional requests for information from HHS and to preliminary audit reports in a timely manner. If an audit results in a finding, issuers must also provide written corrective plans in the time and manner set forth by HHS. Unlike an audit, a compliance review may be targeted at a specific potential error and conducted on an ad hoc basis, which would allow HHS to address situations in which a systematic error or issue is identified during an audit and HHS suspects similarly situated issuers may have experienced the same error or issue but were not selected for audit in the year in question. While these requirements do impose burdens, data collection requirements associated with this audit program and compliance reviews are exempt from PRA requirements in accordance with 5 CFR 1320.4(a)(2) because this information would be collected during the conduct of an administrative action or investigation involving an agency against specific individuals or entities. As a result, although we describe the burdens associated with transitional reinsurance program audits and compliance reviews, we do not include estimates for burdens related to the transitional reinsurance program in the burden tables included at the end of this section.
We anticipate that compliance with reinsurance program audits will take 120 hours by a business operations specialist (at a rate of $76.20 per hour), 40 hours by a computer systems analyst (at a rate of $98.28 per hour), and 20 hours by a compliance officer (at a rate of $72.90 per hour) per issuer per benefit year. The cost per issuer will be approximately $14,533.20. There were 557 issuers participating in the reinsurance program for the 2015 benefit year and 496 issuers participating in the reinsurance program for the 2016 benefit year; however, HHS will only audit a small percentage of these issuers, roughly 30–60 issuers per benefit year. Depending on the number of issuers audited for each benefit year, the total cost to issuers being audited will be between
$435,996 and $871,992, with an average annual cost of approximately $653,994.
We anticipate that reinsurance program compliance reviews will take 30 hours by a business operations specialist (at a rate of $76.20 per hour), 10 hours by a computer systems analyst (at a rate of $98.28 per hour), and 5 hours by a compliance officer (at a rate of $72.90 per hour) per issuer per benefit year. The cost per issuer will be approximately $3,633.30. HHS only intends to conduct compliance reviews for no more than 15 issuers per benefit year and intends to focus these reviews on payments received
by reinsurance-eligible plans under the program. The total annual cost to issuers undergoing compliance reviews will be approximately $54,499.50.
Refunds of Reinsurance Contributions to Contributing Entities
HHS continues to refund contributing entities for overpayments of reinsurance contributions. As a result, we are retaining in this collection reinsurance data elements that issuers are required to provide to HHS in accordance with §153.400(b).
§153.630 and §153.700-§153.730)
Within Part 153, subpart G, we described reporting requirements for health insurance issuers related to the risk adjustment program.
Distributed Data/EDGE Server and Reinsurance and Risk Adjustment Data Submission Requirements (§153.400, §153.420, §153.610, §153.700(a), §153.710, §153.720, and
§153.730)
As described in §§ 153.400(b), 153.420(a), 153.610, and 153.710(a), health insurance issuers are required to maintain reinsurance and risk adjustment data in order for HHS to operate reinsurance and risk adjustment (including the high-cost risk pool) on behalf of a state. HHS has determined that issuers will need to maintain data elements identified in Appendix A. HHS employs a distributed data approach when running risk adjustment on behalf of a state and uses the same data for the purpose of determining the risk adjustment user fee for each issuer. In this update to the Supporting Statement 0938-1155, we included two new data elements in Appendix A, attached, regarding pharmacy claims: the number of days’ supply for prescription drugs and an in/out-of-network claims indicator, to improve our analysis of risk adjustment data.
We began collecting an indicator identifying out-of-network claims from issuers for enrollee-level EDGE data beginning with the 2018 benefit year. We previously established the use of enrollee-level EDGE data for risk adjustment recalibration and to inform the development of the AV calculator and methodology, in addition to using the data for calibrating other HHS individual and small group market programs, in the 2018 Payment Notice and in the 2020 Payment Notice. For the development of the AV calculator and estimating enrollees who reached the maximum annual limitation on cost sharing, HHS relies on identification of claims that were paid on an in-network basis.
Section 1302(c) of the ACA directs the Secretary of HHS to determine an annual premium adjustment percentage, a measure of premium growth that is used to set the maximum annual limitation on cost sharing. Under §156.130(c), issuers cannot be required to include out-of-network claims toward the annual limitation on cost sharing. Therefore, to build the standard population for the AV calculator, HHS must be able to identify out-of-network claims. We believe issuers already collect information on out-of- network claims and estimate a business operations specialist requires 4 hours (at an hourly wage of $76.20) to include this required indicator in the EDGE load, for an approximate cost of $304.80 per issuer. For 650 issuers, we estimate this one-time requirement will incur 2,600 hours and cost $198,120.
Under §153.610(f), we established a user fee to support HHS operation of the risk adjustment program in states that elect not to operate their own risk adjustment program.
9
This per capita monthly fee is charged to issuers of risk adjustment covered plans based on enrollment data provided to HHS in the distributed data environment. HHS calculates risk adjustment user fees, and issuers remit the assessed user fee once annually, in August of the year following the benefit year, in connection with processing payments and charges for risk adjustment. We estimate that approximately 650 issuers will be required to pay risk adjustment user fees, and the additional cost associated with this requirement is the time and effort for an issuer to remit fees. Because HHS utilizes existing data collection and payments and charges processing, we do not anticipate that this provision will alter the collection cost.
Under a distributed data approach, the required data is accessed and stored separately from other issuer data pursuant to formats specified by HHS. In §153.700(a), we require that an issuer of a risk adjustment covered plan or a reinsurance-eligible plan in a state where HHS is operating the risk adjustment or reinsurance program on behalf of the state, as applicable, to provide HHS access to its data through the dedicated data environment as specified by HHS. We estimate that this data submission requirement will affect approximately 650 issuers, and will cost each issuer approximately $556,761.60 in total labor costs, including the data elements we added in Appendix A regarding pharmacy claims: the number of days’ supply for prescription drugs; and an in/out-of-network claims indicator. This cost estimate reflects the wages of 3 full-time equivalent employees (5,760 hours per year) at an average hourly rate of $96.66 per hour for a management analyst. Issuers have already established EDGE servers to process claims, so we are reducing the capital cost in section 13 below to a total of $30,000 for all issuers per year to account for the possibility that only two new EDGE servers would need to be set up annually. For risk adjustment (including high-cost risk pool), we anticipate that 650 issuers will process approximately 9 billion claims and enrollment files annually (approximately 13.8 million claims and enrollment files per issuer). Therefore, we estimate an aggregate annual burden, including labor and capital costs (as described in section 13 below), of $391,895,040 for all issuers as a result of these requirements. To ensure timely and accurate risk adjustment transfers, HHS asks issuers to make complete, current enrollment and claims files accessible through its dedicated distributed data environments no less frequently than quarterly.
HHS has issued guidance giving issuers the option of uploading supplemental diagnoses to their EDGE servers in addition to the other enrollee, claims and medical data elements that are required for the risk adjustment program (see Appendix A). If an issuer chooses to submit supplemental diagnosis information, HHS has determined that issuers will need to maintain the data elements identified in Appendix A. In this collection, we rename 10 data elements in the Supplemental Diagnoses section of Appendix A to accurately reflect existing data specifications for this optional submission. The burden associated with this requirement is the additional effort for an issuer to gather and submit supplemental diagnoses to HHS.
Based on HHS experience from 2019 and 2020 benefit years, we estimate that approximately 85 to 100 percent of the 650 issuers of risk adjustment covered plans will submit this information for 10 percent of their enrollees. Because we estimate that issuers will only submit supplemental diagnoses for 10 percent of their enrollees, we believe that the time and effort associated with this process will be approximately 10 percent of the
time and effort associated with uploading information to the distributed data environment. As an upper level estimate, we anticipate that all 650 issuers will process approximately 900 million supplemental diagnoses claims or about 1.4 million claims per issuer. We estimate that it will take 3 full-time equivalent employees (at an average hourly wage rate of $96.66 for a management analyst) approximately 576 hours per year per issuer to submit supplemental diagnoses to HHS. For 650 issuers, we estimate an aggregate burden of 374,400 hours and $36,189,504 associated with this optional data submission.
As described in §153.720(a), an issuer of a risk adjustment covered plan or reinsurance- eligible plan in a state in which HHS operates risk adjustment or reinsurance, as applicable, must establish a unique masked enrollee identification number for each enrollee, in accordance with HHS-defined requirements, and maintain the same masked enrollee identification number for an enrollee across enrollments or plans within the issuer, within the state, during a benefit year. Under §153.720(b), an issuer of a risk adjustment covered plan or reinsurance-eligible plan in a state in which HHS is operating the risk adjustment or reinsurance program, as applicable, may not include an enrollee’s personally identifiable information in the masked enrollee identification number or use the same masked enrollee identification number for different enrollees enrolled with the issuer. As discussed in OMB Memorandum M-07-16, the term “personally identifiable information” is a broadly used term across federal agencies, and has been defined in the Office of Management and Budget Memorandum M-07-16 (May 22, 2007).1
We estimate that 650 issuers will be affected by the requirement to maintain a masked enrollee identification number for each enrollee. The cost of setting up a masked identity for each enrollee would be the time and effort required to assign an identification number to each enrollee and remove other identifying factors from the enrollee’s profile or claims information as submitted to HHS. We estimate it would cost each issuer approximately
$289.98 per year, based on three hours of work by a management analyst at $96.66 per hour. Therefore, we estimate an aggregate total annual burden of 1,950 hours at an estimated cost of $188,487 for all issuers to maintain a masked enrollee identification number.
Under § 153.710(d) an issuer must either confirm to HHS that the information in the final dedicated distributed data environment report accurately reflects the data to which the issuer has provided access to HHS through its dedicated distributed data environment in accordance with § 153.700(a) for the benefit year specified in the report, or describe to HHS any inaccuracy it identifies in the final dedicated distributed data environment report within 15 calendar days of the date of the report.
We estimate that 650 issuers of risk adjustment covered plans will be subject to this requirement, and that issuers will compare enrollee condition codes with risk scores and analyze claims costs to confirm information in the final dedicated distributed data environment reports. On average, in any given benefit year, we estimate that it will take a business operations specialist (at an hourly wage rate of $76.20) approximately 6 hours to review and respond to the final dedicated distributed data environment report. Therefore, we estimate an aggregate burden of 3,900 hours and $297,180 for 650 issuers as a result
1 Available at: http://www.whitehouse.gov/sites/default/files/omb/memoranda/fy2007/m07-16.pdf.
11
of this requirement.
High-Cost Risk Pool Adjustment (§153.320)
Beginning with the 2018 benefit year, HHS implemented a high-cost risk pool adjustment as part of the risk adjustment program. Beginning with the 2018 benefit year, HHS reimbursed issuers for a percentage of claims amounts above a certain threshold for high- cost enrollees, calculated using EDGE server data and funded by a charge on all issuers of risk adjustment covered plans equal to a percent of premium, by market nationally.
All issuers of risk adjustment covered plans are subject to this high-cost risk pool adjustment. Since HHS will assess charges to all issuers of risk adjustment covered plans to fund the high-cost risk pool adjustment, issuers will be required to submit premium and enrollment data to HHS beginning for the 2018 benefit year, so that HHS can calculate the national high-cost risk pool charge.
Issuers that are the sole issuer in a risk pool will also be required to submit enrollment and premium data, even if they choose not to submit data to the EDGE server due to the lack of a risk adjustment transfer based on plan liability risk scores with another issuer in their risk pool. The burden associated with a submission by an issuer in a single issuer risk pool is included in the burden for the risk adjustment program data submission requirements, as previously described.
State Flexibility for Risk Adjustment (§153.320)
In the 2019 Payment Notice, we finalized a policy to allow State regulators to request a reduction, beginning for the 2020 benefit year, to risk adjustment transfers in the individual, small group or merged markets. Any State requesting this reduction must submit its request with the supporting evidence and analysis to HHS identifying the State- specific factors that warrant the adjustment to more precisely account for the differences in actuarial risk in the State’s individual, small group or merged market. Additionally, the State must submit supporting evidence and analysis demonstrating the reduction percentage requested is appropriate. This evidence and analysis justifying the percentage requested must either demonstrate the set of factors and the percentage by which those factors warrant an adjustment to more precisely account for the differences in actuarial risk in the State’s individual, small group or merged market compared to the national norm, or it must demonstrate the requested reduction in risk adjustment payments would be so small for issuers who would receive risk adjustment payments, that the reduction would have a de minimis effect on the necessary premium increase to cover the affected issuer or issuers’ reduced payments. States are required to submit the requests with the supporting evidence and analysis by August 1st, 2 calendar years prior to the beginning of the applicable benefit year.
The burden associated with this requirement is the time and effort for State regulators to submit a request to reduce risk adjustment transfers to HHS. We estimate that it will take a business operations specialist 40 hours (at a rate of $76.20 per hour) to prepare the request and 20 hours for a senior operations manager (at a rate of $110.82 per hour) to review the request and transmit it electronically to HHS. We estimate that each State seeking a reduction in the average premium calculation will incur a burden of 60 hours at a cost of approximately $5,264.40 per State to comply with this reporting requirement.
Based on experience from prior years, we expect that no more than one state will make state flexibility requests annually, resulting in a total annual burden of approximately 60 hours with an associated total cost of $5,264.40. While these requirements do impose burdens, data collection requirements associated with state flexibility requests are exempt from PRA requirements in accordance with 5 CFR 1320.3(c) because this information would be collected by fewer than ten persons. As a result, although we describe the burdens associated with risk adjustment state flexibility requests, we do not include estimates for these burdens in the burden tables included at the end of this section.
Audits and Compliance Reviews of Issuers of Risk Adjustment Covered Plans (including high-cost risk pool) (§153.620(c))
In the 2022 Payment Notice, we clarified policies around the auditing of issuers of risk adjustment covered plans (including to ensure the proper payment of high-cost risk pool payments) and confirm compliance with applicable requirements in subparts G and H of part 153. Issuers being audited under the risk adjustment program (including high-cost risk pool) will be required to comply with audit requirements including participating in entrance and exit conferences, submitting complete and accurate data to HHS in a timely manner, and providing responses to additional requests for information from HHS and to preliminary audit reports in a timely manner. If an audit results in a finding, issuers must also provide written corrective plans in the time and manner set forth by HHS. Unlike an audit, a compliance review may be targeted at a specific potential error and conducted on an ad hoc basis, which would allow HHS to address situations in which a systematic error or issue is identified during an audit and HHS suspects similarly situated issuers may have experienced the same error or issue but were not selected for audit in the year in question. While these requirements do impose burdens, data collection requirements associated with the risk adjustment program (including high-cost risk pool) audit program are exempt from PRA requirements in accordance with 5 CFR 1320.4(a)(2) because this information would be collected during the conduct of an administrative action or investigation involving an agency against specific individuals or entities. As a result, although we describe the burdens associated with these audits, we do not include estimates for burdens related to these audits in the burden tables included at the end of this section.
We anticipate that compliance with risk adjustment program (including high-cost risk pool) audits will take 120 hours by a business operations specialist (at a rate of $76.20 per hour), 40 hours by a computer systems analyst (at a rate of $98.28 per hour), and 20 hours by a compliance officer (at a rate of $72.90 per hour) per issuer per benefit year. The cost per issuer will be approximately $14,533.20. While the number of issuers participating in the risk adjustment program varies per benefit year, we only intend to audit roughly 30– 60 issuers per benefit year, and intends to focus these audits on payments under the high- cost risk pool. Depending on the number of issuers audited each year, the total cost to issuers being audited will be between $435,996 and $871,992, with an average annual cost of approximately $653,994.
We anticipate that risk adjustment program (including high-cost risk pool) compliance reviews will take 30 hours by a business operations specialist (at a rate of $76.20 per hour), 10 hours by a computer systems analyst (at a rate of $98.28 per hour), and 5 hours by a compliance officer (at a rate of $72.90 per hour) per issuer per benefit year. The cost
13
per issuer will be approximately $3,633.30. While the number of issuers participating in the risk adjustment program varies per benefit year, we only intend to conduct compliance reviews for no more than 15 issuers per benefit year and intends to focus these reviews on payments under the high-cost risk pool. The total annual cost to issuers undergoing compliance reviews will be approximately $54,499.50.
Data Validation Requirements when HHS Operates Risk Adjustment (§153.630)
As described in §153.630, health insurance issuers must comply with risk adjustment data validation activities as specified by HHS or states. The burden associated with this requirement is the issuer’s time and effort to provide HHS with source claims, medical records, and enrollment information to validate enrollee demographic, enrollment and health status information for initial and second validation audits for a sample of enrollees, and the issuer’s cost to employ an independent auditor to perform the initial validation audit on a statistically valid sample of enrollees. While these requirements do impose burdens, data collection requirements associated with HHS-RADV are exempt from PRA requirements in accordance with 5 CFR 1320.4(a)(2) because this information would be collected during the conduct of an administrative action or investigation involving an agency against specific individuals or entities. As a result, although we describe the burdens associated with HHS-RADV, we do not include estimates for these burdens in the burden tables included at the end of this section.
In the 2015 Payment Notice, we revised the audit sample size downward so that each issuer’s audit sample consists of approximately 200 enrollees. As finalized in the 2020 Payment Notice, we used the Neyman allocation methodology beginning with benefit year 2019 HHS-RADV. Based on benefit years 2019 and 2020 HHS-RADV, each issuer’s audit sample consisted of approximately 172 enrollees with HCCs. As finalized in the 2019 Payment Notice, beginning with benefit year 2017 HHS-RADV, issuers with 500 or fewer billable member months statewide are excluded from performing an initial validation audit. As finalized in the 2020 Payment Notice, issuers in liquidation who met certain conditions, sole market risk pool issuers, and small group market issuers with off- calendar year coverage who exit the market but have only carry-over coverage that ends in the next benefit year would also be exempt from HHS-RADV. In addition, starting with 2018 benefit year HHS-RADV, issuers with annual premiums of less than $15 million could be randomly selected to participate in HHS-RADV, while all other issuers could expect to be selected to participate in HHS-RADV, as established in the 2019 Payment Notice. Based on HHS-RADV for benefit years 2018–2020, we estimate that 50 issuers with annual premiums of less than $15 million will be subject to an initial validation audit only every third year. Therefore, we anticipate an upper estimate of 650 issuers would participate in HHS-RADV for any given benefit year.
Under §153.630(b)(1), an issuer of a risk adjustment covered plan must engage one or more independent auditors to perform an IVA of a sample of its risk adjustment data selected by HHS. Under this provision, the issuer must provide HHS with the identity of the initial validation auditor, and attest to the absence of conflicts of interest between the initial validation auditor (or the members of its audit team, owners, directors, officers, or employees) and the issuer (or its owners, directors, officers, or employees), in a timeframe and manner specified by HHS. The additional burden associated with this reporting requirement is the time and effort necessary to report the auditor’s identity to
HHS. Additionally, an issuer must review and attest to its IVA sample or qualify its attestation by submitting a sampling discrepancy. An issuer must also review the IVA findings submitted to the audit tool and complete a signoff action within the audit tool to indicate it concurs with the IVA findings and that its IVA submission is complete. We estimate it will take an operations manager (at an hourly wage rate of $110.82) approximately 30 minutes to complete these reporting requirements. Therefore, for the upper estimate of 650 issuers required to submit reports for HHS-RADV for any given benefit year, the aggregate burden associated with this reporting requirement is 325 hours, at an approximate cost of $36,016.50.
As part of conducting the IVA, the issuer must review the IVA sample and determine which enrollees will require medical records to validate their HCCs. From the enrollees’ claims data, issuers need to determine the source of the claim, for example, the provider submitting the claim and dates of service. The issuer must then request these medical records from various providers. Issuers may request and collect these medical records themselves, include it in their contract with the initial validation auditor, or hire a third party. After requests for medical records are made, tracking of the responses to these requests and additional follow-up is required. In addition, the issuer (or other entity if the issuer has contracted this work to another party), will review the received medical records to ensure they are legible, complete, and include the necessary signatures. If the medical record is not signed, a signature attestation may need to be requested. Based on past experience, approximately 172 enrollees in an issuer sample will require medical records to validate HCCs, with approximately five medical record requests per enrollee (approximately 860 medical record requests per issuer). We estimate it will take a business operations specialist (at an hourly wage rate of $76.20) approximately one hour to complete, review, and conduct follow-up on each medical record request (20 minutes each to complete each medical record request, review the response to each medical record request, and to conduct further follow-up on each medical record request). For each issuer, we anticipate the burden would be approximately 860 hours at a cost of $65,532. For an estimated 650 issuers required to submit samples for HHS-RADV for any given benefit year, we anticipate that the aggregate burden of completing medical record reviews will be approximately 559,000 hours and $42,595,800.
Based on a review of EDGE data for 2017–2019 benefit years, we have determined that for enrollees with HCCs, the average number of HCCs to be reviewed by a certified medical coder per enrollee is approximately three. Additionally, based on HHS audit experience, we estimate that it may cost approximately $398.66 ($59.06 per hour for 6.75 hours on average) for a certified medical coder to review the medical record documentation for one enrollee with roughly three HCCs. For 172 enrollees with HCCs in an issuer sample, the total cost to each issuer would be $68,568.66 (for 1,161 hours).
In some cases, a secondary review by a senior certified medical coder (at an hourly wage rate of $59.06 per hour) will be needed to re-review approximately one-third of the medical record documentation required during the first review. Thus, a senior certified medical coder would need to review medical documentation for the equivalent of approximately 57 enrollees with HCCs in an issuer sample. We estimate that the total cost to each issuer would be approximately $22,723.34 ($59.06 per hour for 6.75 hours per enrollee). For this review and secondary review, the total cost to each issuer would be approximately $91,292 (1,545.75 total hours). In addition, we expect that it may cost
15
approximately $19.69 per enrollee ($59.06 per hour for 20 minutes) to validate demographic information for 50 enrollees in each audit sample totaling $984.33 per issuer. In addition, beginning with 2018 HHS-RADV, an initial validation audit entity is required to conduct a prescription drug category (RXC) review. The audit entity must review RXCs for all adult enrollees in the audit sample with at least one RXC. Based on HHS audit experience, we assume that an initial validation audit will be performed on approximately 71 RXCs per issuer. We estimate that this validation would cost approximately $19.69 per RXC ($59.06 per hour for 20 minutes), totaling $1,397.99 per issuer.
In addition, for each issuer, we expect it would require a compliance officer working 40 hours at $72.90 per hour, and 2 operations managers working a total of 80 hours at
$110.82 per hour to make available to external medical coders associated with the initial validation audit entity claims documents for review of demographic information and RXC review (120 hours at a cost of $11,781.60). The combined burden for reporting, coding, and administration per issuer would be approximately 2,566.58 hours at a cost of
$171,043.33 per issuer. For an estimated 650 issuers required to submit audit findings for HHS-RADV for any given benefit year, we anticipate that the aggregate burden of conducting IVAs will be approximately 1,668,279.17 hours and $111,178,164.50. We note that this is the upper bound burden, and fewer issuers will be subject to this requirement in future years.2
Under §153.630(b)(8), the initial validation auditor is required to attest to HHS that they performed inter-rater reliability (IRR) among their primary coder reviewers using HHS standards or IVA standards approved by HHS until a 95% consistency threshold is achieved. A senior coder must review the medical records of a primary coder that does not meet the 95% consistency threshold. Those findings are documented as the final results on the IVA Entity Audit Results Submission XML. Establishing IRR is a standard practice within the industry, and we therefore believe costs associated with this review are already accounted for in the above estimates.
To reiterate, while these HHS-RADV requirements do impose burdens, data collection requirements associated with HHS-RADV are exempt from PRA requirements in accordance with 5 CFR 1320.4(a)(2) because this information would be collected during the conduct of an administrative action or investigation involving an agency against specific individuals or entities. As a result, although we describe the burdens associated with HHS-RADV, we do not include estimates for these burdens in the burden tables included at the end of this section.
Mental and behavioral health records §153.630
For risk adjustment data validation, HHS requires issuers to document mental and behavioral health records included in audit sampling. Without the necessary mental and behavioral health information for each sample, the diagnosis code for an applicable enrollee cannot be validated and, therefore, it would be rejected during risk adjustment data validation.
2 As a result of the policies in the 2019 and 2020 Payment Notices that established exemptions from HHS-RADV for certain issuers, fewer than 650 issuers each year will be subject to this requirement in future years.
Because providers may be prevented under some state privacy laws from furnishing a full mental health or behavioral health record, we provided issuers in the 2019 Payment Notice at §153.630(b)(6) an additional avenue to achieve compliance with data validation requirements by permitting abbreviated mental or behavioral health assessments for risk adjustment data validation in the event that a provider is subject to state privacy laws that prevent the provider from providing HHS with a complete mental or behavioral health record. To submit a mental or behavioral health assessment, a provider would be required to attest that relevant state privacy laws prevent him or her from providing the entire mental or behavioral health record.
HHS expects that this provision may affect 10 percent of issuers or approximately 65 issuers in states with stricter privacy laws on medical records. Based on data from 2017 and 2018 initial validation audits, we estimate that approximately 10 enrollees in any initial validation audit sample of 200 enrollees could be affected by the stricter privacy laws. Providers routinely prepare assessments to validate diagnoses, therefore, we believe the additional burden is the time it would take to seek patient consent to provide the assessment, in states that require such permission, and for a provider to prepare an abbreviated assessment for each medical record and to attest that relevant state privacy laws prohibit him or her from providing the entire mental or behavioral health record.
We estimate it would take a medical records technician (at an hourly wage of $46.46) 15 minutes to obtain consent from each patient, or approximately 2.5 burden hours at an estimated cost of $116.15 per issuer. In addition, we estimate a qualified licensed provider (at an hourly wage of $240.16) would need 45 minutes to prepare an abbreviated assessment and sign an attestation, for a total of $180.12 per enrollee, or $1,801.20 per issuer. Therefore, for 10 patients, the total burden per issuer for the provision to obtain consent from each patient and prepare an abbreviated assessment and signed attestation would be 10 hours and approximately $1,917.35. The aggregated burden for the estimated 65 affected issuers would be 650 hours and approximately $124,627.75.
17
Table 1 - Burden Estimates for Risk Adjustment Data Collection and Data Validation
Information Collection Requirement |
Type of Respondent |
Frequency and Duration |
Number of Respondents |
Total Burden Hours |
||
Issuer |
Annually |
650 |
1 |
4 |
2,600 |
|
Issuer |
Annually |
650 |
1 |
|
|
|
Supplemental diagnoses |
Issuer |
Annually |
650 |
1 |
576 |
374,400 |
Issuer |
Annually |
650 |
1 |
3 |
1,950 |
|
Respond to the final distributed data report |
Issuer |
Annually |
650 |
1 |
6 |
3,900 |
Total |
|
|
|
|
|
4,126,850.00 |
Table 2 - Burden Estimates for Risk Adjustment Data Collection and Data Validation by Labor Category
Under § 156.1220 and associated guidance, issuers may use an administrative appeal process to address unresolved discrepancies for the premium stabilization programs, as well as any assessment under §153.740(b) of a default risk adjustment charge. While these requirements do impose burdens, data collection requirements associated with appeals are exempt from PRA requirements in accordance with 5 CFR 1320.4(a)(2) because this information would be collected during the conduct of an administrative action or investigation involving an agency against specific individuals or entities. As a result, although we describe the burdens associated with the appeals process, we do not include estimates for these burdens in any burden table.
Under § 156.1220(a), which includes programs that expired in 2016, an issuer may file a request for reconsideration to contest a processing error by HHS (i.e., an incorrect loading or use of data), an incorrect application of the relevant methodology, or a mathematical error for: (1) the amount of risk adjustment payments or charges (including high-cost risk pool) for a benefit year, including an assessment of risk adjustment user fees; (2) the amount of reinsurance payments for a benefit year; (3) the amount of a risk adjustment default charge for a benefit year; (4) the amount of risk corridors payments or charges for a benefit year; (5) the findings of a second validation audit as a result of risk adjustment data validation (if applicable) with respect to risk adjustment data for the 2016 benefit year and beyond;3 or (6) the calculation of a risk score error rate as a result of risk adjustment data validation with respect to risk adjustment data for the 2016 benefit year and beyond.4 While the hours involved in a request for reconsideration may vary, for the purpose of this burden estimate we estimate that it will take a business operations specialist 4 hours (at an hourly wage rate of $76.20) to make the comparison and submit a discrepancy report, if applicable, and a request for reconsideration to HHS. We estimate that less than 11 issuers that may be eligible for reinsurance payments, risk adjustment payments or charges (including high-cost risk pool payments and charges, HHS-RADV adjustments to risk adjustment transfers, any assessment of risk adjustment user fees or a default risk adjustment charge) will submit a request for reconsideration for any of these programs for a total aggregate burden related to appeals of approximately 44 hours and an estimated cost of $3,352.80.
Additionally, under §156.1220(b), an issuer dissatisfied with the reconsideration decision regarding: (1) risk adjustment payments and charges, including an assessment of risk adjustment user fees, (2) reinsurance payments, (3) default risk adjustment charges, (4) risk corridors payments or charges, (5) second validation audit findings (as applicable), or (6) risk score error rate calculations, provided under paragraph (a) of §156.1220, is entitled to an informal hearing before a CMS hearing officer, if a request is made in writing within 30 calendar days of the date the issuer receives the reconsideration decision. Further review is available from the CMS Administrator. However, because we believe these processes will occur extremely infrequently, we are not estimating the burden related to this requirement.
3 Benefit year 2016 HHS-RADV was a pilot year. See HHS-RADV Amendments Rule, 85 FR at 76980. As such, this provision applies to benefit year 2017 HHS-RADV and beyond.
19
Regardless of the data format and specifications for the risk adjustment program, issuers will need to extract and, for purposes of audit, store the necessary data elements separately from data used during the normal course of business. We now estimate that in any given year, two new issuers will need to establish an EDGE server and that the one-time cost will be on average $15,000. Therefore, we estimate a total capital burden for all issuers subject to this requirement of $30,000. This estimate does not include the labor costs associated with data and server maintenance, which are estimated separately.
We estimate the annual cost to the federal government annually in each applicable benefit year’s Payment Notice. For the 2022 benefit year, we estimated that the total cost for HHS to operate the risk adjustment program (jncluding HHS-RADV and high-cost risk pool) on behalf of states will be approximately $60 million. The calculations for CCIIO employees’ hourly salary were obtained from the OPM website https://www.opm.gov/policy-data-oversight/pay- leave/salaries-wages/.
Table 3 – Administrative Burden Costs for the Federal Government Associated with the Risk Adjustment and Reinsurance Programs
This reinstatement with change includes a significant decrease in burden due to the termination of the risk corridors program, from 19,650,586 to 4,126,850 hours. Also, based on the past years of experience with the risk adjustment program (including HHS-RADV), we substantially reduced the number of issuers participating in the risk adjustment program by more than two thirds, to 650 from 2,400.
Publication/Tabulation Dates
The data collection will be published for this reinstatement with change.
The expiration date and OMB control will be displayed on each instrument (first page, top right corner).
File Type | application/vnd.openxmlformats-officedocument.wordprocessingml.document |
File Title | CMS-10401 3Rs Supporting Statement |
Author | CMS |
File Modified | 0000-00-00 |
File Created | 2022-07-12 |